TRAY NESMITH: Open Payments
NPI 1871933986 · ARAB, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 23 payments from 9 companies in 2025. Trend: 2023 $609 · 2024 $114 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $88 |
| Antares Pharma, Inc. | 4 | $84 |
| Novo Nordisk Inc | 3 | $62 |
| Amgen Inc. | 3 | $62 |
| Exact Sciences Corporation | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: XYOSTED, VRAYLAR, Kerendia, OTEZLA, Ozempic, Cologuard Collection Kit, Qelbree, ZEPBOUND.
Industry payments across AL — which companies pay providers there.
